Received Sep 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (PNEUMOVAX) | MERCK & CO. INC. | UNK | — | — |
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
pneumonia; pneumonia; pneumonia; pneumonia; pneumonia; pneumonia; pneumonia; This spontaneous report was received from a pharmacist on 03-Sep-2025, referring to an 82-year-old male patient. The patient's medical history was not reported. The patient's concurrent conditions included COPD. Concomitant medications included Steroids. On an unknown date, the patient was vaccinated with Pneumococcal Vaccine, Polyvalent (23-valent) (PNEUMOVAX 23), Pneumococcal vaccine conj 7v (CRM197) (PREVNAR) (reported as PREVNAR 12, conflicting information) (lot # and expiration date were not reported) as vaccination due to high risk of contracting pneumonia. In approximately 1995 (reported as about 30 years ago), he had pneumonia 6 times in 1 year. Most recent history of pneumonia was 2023. In June 2024, the patient was vaccinated with Pneumococcal vaccine conj 20v (CRM197) (PREVNAR 20). At the time of reporting, the outcome of the events was unknown. The action taken with the suspect vaccines was not applicable. The causal relationship between the events and the suspect vaccines was not provided. Upon internal review, the events of pneumonia were determined to be medically significant.
COPD
Steroid